Hironik showcased its medical device technology at the 2026 Fall Conference of the Korean Society for Aesthetic and Obesity Regenerative Medicine (KORA) on October 11.


KORA 2026 HIRONIC booth. HIRONIC

KORA 2026 HIRONIC booth. HIRONIC

View original image

According to Hironik on October 14, the company exhibited products and promoted its brand at the conference, focusing on MIGLOU, which received product approval from the Ministry of Food and Drug Safety last July. MIGLOU is a medical device that uses 2.45-gigahertz (GHz) microwave energy and focused high-intensity microwave (FIM) technology.

 

In addition to MIGLOU, the company introduced its new product Synerjet Pro, which began supplying clinics and hospitals in August, and its steady seller, V-RO Lifting. Synerjet Pro is a needle-free injector medical device that uses three technologies, including low-frequency stimulation using microjet and electroporation (EP) tips, as well as plasma. V-RO Lifting is a dual-energy medical device that combines high-intensity focused ultrasound (HIFU) and radiofrequency (RF), and is one of Hironik's flagship products.



A Hironik representative said, "KORA 2026 was a meaningful opportunity to showcase the technology behind key products, including MIGLOU, and to communicate directly with medical professionals. We will continue to participate in academic conferences and medical device exhibitions at home and abroad to promote our products' competitiveness and expand our engagement with medical professionals."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing